Past, present and future of prognostic scores in follicular lymphoma. (November 2021)

• Record Type: Journal Article
• Authors: Mozas, Pablo; Rivero, Andrea; López-Guillermo, Armando
• Is Part Of: Blood reviews. Volume 50(2021)
• Publication Date: 2021-11
• Subjects: Follicular lymphoma -- Prognostic indexes -- Survival; Hematology -- Periodicals; Hematology -- Periodicals; Hématologie -- Périodiques; Hematology; Electronic journals; Periodicals; 616.15
• DOI: 10.1016/j.blre.2021.100865
• Languages: English
• ISSNs: 0268-960X

Abstract

Abstract: Although most follicular lymphoma (FL) patients have prolonged survival, the identification of those at risk of early progression, multiple relapses or histological transformation is essential for the improvement of long-term outcomes. In this sense, a plethora of prognostic indexes have been developed in the last decades. However, determining which one is more accurate and clinically meaningful remains a challenge. Key factors for the external validity of available indexes include characteristics of the study population, treatment intervention, and design of the study. While initial risk scores were composed of clinical, biochemical, and hematological variables, genomic and imaging data have been incorporated in recent years. Despite an obvious step forward in the knowledge of the natural history and biology of FL, predictions remain inaccurate. Further research will likely incorporate information from circulating tumor DNA and artificial intelligence models to refine the prognostic classification of the heterogeneous FL population.